| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |